The evolution of cancer care is advancing so quickly, it’s nearly impossible to keep up. Genetic sequencing has radically improved our ability to get the right drug to the right patient—improving outcomes for both patients and practices. But policy is unclear, lab testing is interpreted differently, and funding is available—but how do you get it?
In this episode, we are joined by Dr. Howard McLeod (internationally recognized expert in precision medicine and medical director for precision medicine at the Geriatric Oncology Consortium) and Dr. Jai Patel (chair of the department of cancer pharmacology and pharmacogenomics at Atrium Health’s Levine Cancer Institute) who dive into the paradigm shift in cancer care, the role of genomic testing and sequencing, and navigating policy to your practice’s advantage.
Learn more about our partners at VieCure.
The content and information contained in this podcast is provided [exclusively or solely] by VieCure and AmerisourceBergen is not responsible and does not verify for accuracy any of the information contained in the podcast. The primary purpose of the podcast is to educate and inform. This podcast does not constitute medical or other professional advice or services.